Conor McNamara
Stock Analyst at RBC Capital
(1.34)
# 3,626
Out of 5,090 analysts
141
Total ratings
35.92%
Success rate
-10.64%
Average return
Main Sectors:
Stocks Rated by Conor McNamara
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Upgrades: Outperform | $61 → $73 | $61.68 | +18.35% | 11 | Sep 3, 2025 | |
| MRVI Maravai LifeSciences Holdings | Maintains: Outperform | $7 → $5 | $3.70 | +35.14% | 7 | Aug 12, 2025 | |
| NTRA Natera | Maintains: Outperform | $251 → $255 | $244.55 | +4.27% | 2 | Aug 8, 2025 | |
| OABI OmniAb | Maintains: Outperform | $4 → $3 | $1.95 | +53.85% | 4 | Aug 7, 2025 | |
| EXAS Exact Sciences | Maintains: Sector Perform | $54 → $46 | $101.06 | -54.48% | 1 | Aug 7, 2025 | |
| HOLX Hologic | Upgrades: Outperform | $72 → $87 | $74.97 | +16.05% | 12 | Aug 6, 2025 | |
| AVTR Avantor | Maintains: Outperform | $20 → $17 | $10.93 | +55.54% | 9 | Aug 4, 2025 | |
| ILMN Illumina | Maintains: Outperform | $118 → $126 | $128.96 | -2.30% | 16 | Aug 1, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $317.69 | +28.74% | 14 | Aug 1, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Outperform | $387 → $409 | $317.05 | +29.00% | 14 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $193 → $204 | $164.98 | +23.65% | 12 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $651 → $637 | $572.77 | +11.21% | 14 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $250 | $226.25 | +10.50% | 10 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $64 → $61 | $27.76 | +119.74% | 11 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $8 → $7 | $4.85 | +44.33% | 4 | Aug 7, 2024 |
Bio-Techne
Sep 3, 2025
Upgrades: Outperform
Price Target: $61 → $73
Current: $61.68
Upside: +18.35%
Maravai LifeSciences Holdings
Aug 12, 2025
Maintains: Outperform
Price Target: $7 → $5
Current: $3.70
Upside: +35.14%
Natera
Aug 8, 2025
Maintains: Outperform
Price Target: $251 → $255
Current: $244.55
Upside: +4.27%
OmniAb
Aug 7, 2025
Maintains: Outperform
Price Target: $4 → $3
Current: $1.95
Upside: +53.85%
Exact Sciences
Aug 7, 2025
Maintains: Sector Perform
Price Target: $54 → $46
Current: $101.06
Upside: -54.48%
Hologic
Aug 6, 2025
Upgrades: Outperform
Price Target: $72 → $87
Current: $74.97
Upside: +16.05%
Avantor
Aug 4, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $10.93
Upside: +55.54%
Illumina
Aug 1, 2025
Maintains: Outperform
Price Target: $118 → $126
Current: $128.96
Upside: -2.30%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $317.69
Upside: +28.74%
Bio-Rad Laboratories
Aug 1, 2025
Maintains: Outperform
Price Target: $387 → $409
Current: $317.05
Upside: +29.00%
Jul 30, 2025
Maintains: Outperform
Price Target: $193 → $204
Current: $164.98
Upside: +23.65%
Apr 24, 2025
Maintains: Outperform
Price Target: $651 → $637
Current: $572.77
Upside: +11.21%
Apr 23, 2025
Reiterates: Outperform
Price Target: $250
Current: $226.25
Upside: +10.50%
Feb 13, 2025
Maintains: Outperform
Price Target: $64 → $61
Current: $27.76
Upside: +119.74%
Aug 7, 2024
Maintains: Outperform
Price Target: $8 → $7
Current: $4.85
Upside: +44.33%